Bacterial Meningitis in Burkina Faso: Surveillance Using Field-Based Polymerase Chain Reaction Testing
Clinical Infectious Diseases2004Vol. 40(1), pp. 17–25
Citations Over TimeTop 10% of 2004 papers
Isabelle Parent du Châtelet, Yves Traoré, Bradford D. Gessner, Aude Antignac, B. Naccro, Berthe‐Marie Njanpop‐Lafourcade, M. Ouédraogo, S Tiendrébéogo, E. Varon, Muhamed‐Kheir Taha
Abstract
Precise and rapid identification of etiologic agents is critical for improvement in the treatment and prevention of meningitis, and, thus, PCR should be considered for wider use in Africa. Vaccines against Streptococcus pneumoniae, N. meningitidis (including serogroup W135), and H. influenzae type b all will have a major impact on the bacterial meningitis burden. Antibiotic recommendations need to consider the importance of S. pneumoniae, even during the epidemic season.
Related Papers
- → Surveillance of Bacterial Meningitis, Ethiopia, 2012–2013(2015)20 cited
- → Enteroviral Meningitis: Diagnostic Methods and Aspects on the Distinction from Bacterial Meningitis(1992)10 cited
- → Correlation between leukocyte aggregation score of cerebrospinal fluid and bacterial meningitis in children(2016)1 cited
- → Epidemiological profile of bacterial meningitis in the state of São Paulo(2021)
- → Bacterial Meningitis(2021)